Download PDF

Other users also viewed these articles

Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis José María Álvaro-Gracia Álvaro; Petra Díaz del Campo Fontecha; José Luis Andréu Sánchez; Alejandro Balsa Criado; Rafael Cáliz Cáliz; Isabel Castrejón Fernández; Hèctor Corominas; José A. Gómez Puerta; Sara Manrique Arija; Natalia Mena Vázquez; Ana Ortiz García; Chamaida Plasencia Rodríguez; Lucía Silva Fernández; Jesús Tornero Molina;
Reumatol Clin. 2024;20:423-39
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology Javier Narváez; Myriam Aburto; Daniel Seoane-Mato; Gema Bonilla; Orlando Acosta; Gloria Candelas; Esteban Cano-Jiménez; Iván Castellví; José María González-Ruiz; Héctor Corominas; Belén López-Muñiz; María Martín-López; Alejandro Robles-Pérez; Natalia Mena-Vázquez; José Antonio Rodríguez-Portal; Ana María Ortiz; Cristina Sabater-Abad; Isabel Castrejón; Raquel dos Santos; Sandra Garrote-Corral; Jesús Maese; Lucía Silva-Fernández; Santos Castañeda; Claudia Valenzuela;
Reumatol Clin. 2023;19:74-81
Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting Sara Marsal Barril; Mª Auxiliadora Martin-Martinez; Francisco Javier Blanco-Garcia; Antonio Fernández-Nebro; Rosario García de Vicuña; Jesús Tornero-Molina; Fernando Sánchez-Alonso; Marta Novella-Navarro; Alejandro Escudero-Contreras; Juan José Alegre-Sancho; Ana Urruticoechea-Arana; Maria Sagrario Bustabad-Reyes; Pilar Trenor-Larraz; Trinidad Pérez-Sandoval; Maria Isabel Tevar-Sánchez; Jesús T. Sánchez-Costa; Enrique Raya-Álvarez;
Reumatol Clin. 2022;18:567-73